Corneal cross-linking v liečbe keratokónusu--výsledky a komplikácie v dvojročnom sledovaní
[Treatment of Keratoconus with Corneal Cross-linking--Results and Complications in 2 Years Follow-up]
Language Czech Country Czech Republic Media print
Document type Comparative Study, Journal Article
PubMed
26201362
PII: 52695
- MeSH
- Time Factors MeSH
- Adult MeSH
- Photochemotherapy methods MeSH
- Photosensitizing Agents therapeutic use MeSH
- Keratoconus diagnosis drug therapy MeSH
- Collagen * MeSH
- Humans MeSH
- Follow-Up Studies MeSH
- Corneal Pachymetry MeSH
- Disease Progression MeSH
- Prospective Studies MeSH
- Cross-Linking Reagents therapeutic use MeSH
- Treatment Outcome MeSH
- Visual Acuity drug effects MeSH
- Check Tag
- Adult MeSH
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Comparative Study MeSH
- Names of Substances
- Photosensitizing Agents MeSH
- Collagen * MeSH
- Cross-Linking Reagents MeSH
OBJECTIVE: The objective of the study was to assessment of changes of monitored parameters after CXL. Incidence of complications were assessed in the whole group and in groups of patients divided according to the selected criteria. Evaluated parameters were also relations between them and in time. METHODS: The 86 eyes of patients with progressive keratoconus who underwent CXL according to the Dresden protocol in the years 2007-2009 at the Ophthalmic clinic FN Brno Bohunice were included in this study. RESULTS: There was observed significant increase of BCVA (letters--before CXL 42,30±10,35, 1st year after CXL (1Y) 44,68±10,04, p<0,01, 2nd year after CXL (2Y) 44,44±10,57, p<0,01) and SE (-5,95±3,98D, -5,27±3,84D, p<0,01, -4,94±3,68D, p<0,01), and decrease of maximum curvature of the cornea (MAX--before CXL 50,39±4,17D, 1Y 49,46±4,13D, p<0,01, 2Y 49,42±4,14D, p<0,01). Change of ultrasound CCT, polymegatisms, pleomorfisms and corneal endothelial cell density was not significant. The value of MAX is the most important parameter in estimating the effect of CXL. The highest incidence of corneal opacity after CXL was observed in the eyes of patients with III. stage of keratoconus over 40 years old, carrying hard contact lenses and with biomikroskopic symptom of keratoconus on the cornea. We found that corneal thickness measurement with Orbscan II and the mesurement of IOP with noncontact method is incorrect by patients after CXL. CONCLUSION: Corneal cross-linking of the cornea is safe and effective procedure of stopping the progression of keratoconus in 97% of eyes in the period up to 2 years after CXL.